Authors: FALKENBURG JHF SCHAAFSMA MR SMITH WM KLUINNELEMANS JC HOOFTMANDENOTTER A RIJNBEEK M VANDEMAREL A SCHELLEKENS M BRANDELY M FIBBE WE WILLEMZE R

Citation: Jhf. Falkenburg et al., TREATMENT WITH LOW-DOSE IL-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 2252-2252

Authors: FALKENBURG JHF FABER LM VANDENELSHOUT M VANLUXEMBURGHEIJS SAP HOOFTMANDENOTTER A SMIT WM VOOGT PJ WILLEMZE R

Citation: Jhf. Falkenburg et al., GENERATION OF DONOR-DERIVED ANTILEUKEMIC CYTOTOXIC T-LYMPHOCYTE RESPONSES FOR TREATMENT OF RELAPSED LEUKEMIA AFTER ALLOGENEIC HLA-IDENTICALBONE-MARROW TRANSPLANTATION, Journal of immunotherapy with emphasis on tumor immunology, 14(4), 1993, pp. 305-309

Authors: FALKENBURG JHF HOOFTMANDENOTTER A VANDERELSHOUT M VANDERMAREL A KLUINNELEMANS JC SCHAAFSMA MR FIBBE WE BRANDELY M WILLEMZE R

Citation: Jhf. Falkenburg et al., LOW-DOSE IL-2 DURING 6 MONTHS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOID-LEUKEMIA (AML), Experimental hematology, 21(8), 1993, pp. 1119-1119